Opaleye Management Inc. - Jul 26, 2022 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role: 10%+ Owner
Signature: Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol: TCON
Transactions as of: Jul 26, 2022
Transactions value $: $3,877
Form type: 4
Date filed: 7/26/2022, 05:25 PM
Previous filing: Jul 22, 2022
Next filing: Aug 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCON	Common Stock, par value $0.001 per share	Purchase	$3.88K	+2.25K	+0.61%	$1.72	370K	Jul 26, 2022	By Managed Account.	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TCON	Prefunded Warrants						1.89M	Jul 26, 2022	Common Stock	1.89M	$0.01	By Opaleye,L.P.	F2, F3
holding	TCON	Prefunded Warrants						1.36M	Jul 26, 2022	Common Stock	1.36M	$0.01	By Opaleye,L.P.	F2, F3
holding	TCON	Prefunded Warrants						2.21M	Jul 26, 2022	Common Stock	2.21M	$0.01	By Opaleye, L.P.	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F2	Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F3	The warrants may not be exercised to the extent that such exercise would cause the reporting person and its affiliates to beneficially own more than 19.99% of the Issuer's then outstanding common stock.